ATEC Sees Chance to Run the Table in Spine
The company grew more than 20% in the first quarter of 2025 as it seeks to cement itself as the largest pure-play spine company. May 06, 2025
Stryker Maintains Execution and Growth Edge in Q1
The company maintained its exceptional pace of orthopedic growth during the first quarter of 2025 driven by execution and robotic procedures. May 05, 2025
Smith+Nephew Q1 Performance Highlighted by Robotics and Trauma
The company grew in the low single digits in the first quarter of 2025 as it incrementally improves its performance. May 02, 2025
CONMED Makes Progress on Supply Chain in Q1
The company's orthopedic sales grew in the low single digits in the first quarter as it attempts to improve its supply chain. May 01, 2025
What We’re Watching: 2025 First Quarter Earnings Results
A look at how the market's 2024 finish, resurgent M&A volume and the potential impact of tariffs on the orthopedic industry. Apr 22, 2025
J&J MedTech Starts Slow in 2025, Eyes Second Half
One-time events and competitive pressures created a slower start to 2025 for J&J MedTech's orthopedic sales. Apr 17, 2025
Smith+Nephew Faces Crucial Test in 2025
Smith+Nephew's 12-Point Plan is working and driving improved performance for the company. But is it working fast enough? Apr 09, 2025
The State of Enabling Technology in 2025
We expect healthy demand, more competitive pressure at the top of the market and a focus on creating optionality within tech portfolios. Mar 11, 2025
Digital and Obio Assets in Greater Demand for M&A
Over the last four years, spine M&A volume declined significantly while digital and orthobiologic assets saw increased activity. Mar 10, 2025
Orthopedic Executives Reflect on Transformational 2024
Selected comments from the leaders of top orthopedic companies as they reported fourth quarter 2024 earnings. Mar 05, 2025
